In addition to morules, we showed that SATB2 expression by tumor cells is extremely rare in endometrial cancer; thus, SATB2 can be reliably used in the diagnostic evaluation of a uterine endometroid or serous carcinoma, if necessary. This evidence concerns the gene SATB2 and endometrial cancer.